Page last updated: 2024-08-16
rbi 257 and l 745870
rbi 257 has been researched along with l 745870 in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Hopkins, CR; Lindsley, CW | 1 |
| Bonifazi, A; Cifani, C; Del Bello, F; Fontana, S; Giorgioni, G; Mammoli, V; Matucci, R; Micioni Di Bonaventura, MV; Petrelli, R; Piergentili, A; Quaglia, W; Vistoli, G; Yano, H | 1 |
Reviews
1 review(s) available for rbi 257 and l 745870
| Article | Year |
|---|---|
Return of D
Topics: Animals; Drug Discovery; Humans; Ligands; Molecular Targeted Therapy; Neoplasms; Parkinson Disease; Receptors, Dopamine D4; Small Molecule Libraries; Substance-Related Disorders | 2017 |
Other Studies
1 other study(ies) available for rbi 257 and l 745870
| Article | Year |
|---|---|
1-[3-(4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1) as a Model for the Rational Design of a Novel Class of Brain Penetrant Ligands with High Affinity and Selectivity for Dopamine D
Topics: Animals; Brain; CHO Cells; Cricetulus; Dopamine Antagonists; Drug Design; Guinea Pigs; HEK293 Cells; Humans; Ligands; Male; Mice; Molecular Docking Simulation; Piperidines; Quinolones; Rats; Receptors, Dopamine D4 | 2018 |